November 17, 2024
Artificial intelligence (AI) helps produce echocardiograms more quickly and efficiently, with better-quality images and less fatigue for operators, shows the first prospective randomized controlled trial of […]
November 17, 2024
CHICAGO — An intensive treatment approach to lower systolic blood pressure to a target of 120 mm Hg in patients with type 2 diabetes led to […]
November 16, 2024
CHICAGO — A new study has shown for the first time that a drug therapy can reduce major heart failure clinical outcomes in patients with heart […]
November 13, 2024
WASHINGTON — A phase 3 randomized trial will soon begin for the first transcatheter aortic valve replacement (TAVR) device for the treatment of aortic valve regurgitation […]
November 13, 2024
WASHINGTON, DC — Large-bore mechanical thrombectomy is superior to catheter-directed thrombolysis for pulmonary embolism, according to a randomized trial comparing the two interventions. Although there was […]
November 13, 2024
WASHINGTON — Colchicine does not protect against major cardiovascular adverse events after an acute myocardial infarction, according to a multinational placebo-controlled trial of more than 7000 […]
November 13, 2024
TOPLINE: Cardiac arrest survivors with complete neurologic recovery at hospital discharge show significantly improved long-term survival rates, found a study. METHODOLOGY: Researchers analyzed data from four […]
November 12, 2024
WASHINGTON — A variety of stent designs have tried and failed to reduce the number of stent-related adverse events over time, but now a new device […]
November 12, 2024
WASHINGTON, DC — Atherectomy has no advantage over conventional balloon angioplasty for the treatment of severe calcified lesions, according to unexpected results from the largest trial […]